Pharmaceutically active zinc complexes

Details Pharmaceutically active zinc complexes Pharmaceutically active zinc complexes

1987-02-18

1990-01-16

Schenkman, Leonard

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

556120, 556125, C07F 980

Patent

active

048944556

ABSTRACT:
Zinc(II) complexes in which at least one ligand is provided by a compound being:

REFERENCES:
patent: 2904573 (1959-09-01), Oroshnik et al.
patent: 3130204 (1964-04-01), Tate et al.
patent: 3236733 (1966-02-01), Karsten et al.
patent: 3281366 (1966-10-01), Judge et al.
patent: 3968118 (1976-07-01), Lohans et al.
patent: 4018907 (1977-04-01), Scarpellino
patent: 4225614 (1980-09-01), Hansson
patent: 4279936 (1981-07-01), Jones et al.
patent: 4442305 (1984-04-01), Weitl et al.
patent: 4543213 (1985-09-01), Weitl et al.
patent: 4575502 (1986-03-01), Hider et al.
patent: 4575502 (1986-03-01), Hider et al.
patent: 4587240 (1986-05-01), Hider et al.
Reedijk et al--Recueil des Travaux Chimiques des Pays Bas et de la Belgique, 1972, vol. 91, pp. 681-687.
Gerard et al--Journal of Chemical Research, 1978 (M) pp. 4175-4186 and (S) 404-405.
Morita et al--Bulletin of the Chem. Soc. of Japan, 1976, vol. 49, pp. 2461-2464.
Stunz et al--Australian Journal of Chem., 1979, vol. 32, pp. 21-30.
Evans--Biological Aspects of Metals and Metal-Related Deseases (Ed. B. Sparken) New York 1983, pp. 81-88.
Bull. Soc. Chim. (1979), No. 11-12, pp. I-451 to I-456.
J. Chem. Res. (1978), (M), pp. 4875-4886 and (S),. 404-405.
J. Am. Chem. Soc. (1957) vol. 79, pp. 1296-1297.
Bull. Chem. Soc. Japan (1976) vol. 49, pp. 2461-2464.
Bull. Soc. Chim. France (1967), No. 8, pp. 2920-2923.
CA 68:8872k.
CA 77:101817s.
Solomons "Nutritional . . . of Zinc" Symposium Series Am. Chem. Soc., 1983, vol. 210, pp. 247-271.
CA 89:35629b.
Am. J. Dis. Child (1983) vol. 137, pp. 433-437.
Aggett et al, "Zinc Deficiency in Human Subjects" (1983) pp. 117-124.
Prasad "Biological Aspects of Metal . . . "(1983) pp. 107-119.
"The Economist" (1984) (Mar. 24) pp. 82-83.
Symposium Proceedings, Bethesda, MD (1975) pp. 137-173.
Aust. J. Biol. Sci., 1976, 29, pp. 189-196.
Croatica Chemica Acta CCACAA, 1973, 45, pp. 603-610.
J. Chem. Soc., Dalton Trans., (1982) pp. 1433-1438.
Ann. Chim., (Rome), vol. 66, Nos. 7-8, 1976, pp. 401-415.
Rec. Trav. Chim., 65:65 (1946).
CA 97:173875.
CA 87:157681s.
J. Chem. Soc., 69:1801 (1947).
Helvetica Chimica Acta, vol. XXIX, Fasciculus XII (1946), pp. 1669-1675.
Yakugaku Zasshi J. Pharm., 90 (10):1222-5 (1970).
Tetrahedron (1970), vol. 26, pp. 3779-3785.
J. Bacteriology, (Jan. 1980) vol. 141, No. 1, pp. 164-168.
CA 85:56109q.
Tolanta (1974), 21, pp. 763-769.
Chem. Abst. vol. 75, No. 18 (Nov. 1, 1971) 115362k.
Martindale, the Extra Pharmacopoeia, The Pharm. Press, 1973, pp. 81 and 739.
Pitt and Gupta, Development of Iron Chelators for Clinical Use, Anderson and Hiller (EPS), 1975, pp. 137-173.
Pfizer Tech. Bulletin, Data Sheet No. 04/A/Mar., 1974.
Pfizer Tech. Bulletin, No. 865.
Chem. Abst. 94, 1981, 4114j.
Chem. Abst. 94, 1981, 24201h.
Biochem. Pharm., 29, 1980, 1275.
J. Pharm. and Experim. Therapeutics, 196, 1976, 478.
Brit. Journal of Hematology, 33, 1976, pp. 487-495, White et al.
J. of Pharm. Sci., 61, 1972, 1209, Foye et al.
Collection of Czech. Chemical Comm., 33, Feb. 5, 1968, pp. 4198-4124.
Chem. Pharm. Bull. (1980), 28(9), pp. 2570-2579.
J. of Bacteriology, Jan. 1980, pp. 164 et seq. Akers et al.
Am. Journal of Clinical Nutrition, Jan. 1964, pp. 47-51, Bothwell et al.
J. of Coord. Chem., 8, 1978, p. 27, Habeeb et al.
J. Chem. Research, 1980, 314, Gerard et al.
Nempo, 18, 1970, 16-21.
Merck Index, 9th Ed. (1976) (Merck & Co. Rahway, N.J.), pp. 543-544.
CA 94:156749c.
CA 98:71930n.
Manufacturing Chemist in Aerosol News (May 1970), by E. Jones, "Production of Enteric Coated Capsules".
CA 97:92048a.
Bol. Soc. Chil. Quim. (1982) 27, pp. 122-124.
Lieberman, H. A. and Lachman, L.: Pharmaceutical Dosage Forms, vol. 3 (1982), Marcel Decker, pp. 165-167.
Maxton, D. G.; Thompson, R. P. H.; and Hider, R. C., "Report of Iron Uptake from Fe(III) (Maltol, Human Studies" (Jan. 1986).
Skikne, Feb. 14, 1986 Letter.
Blake, "Study to Compare the Effect of Iron Maltol . . . ".
Struct. Bonding (Berlin) (1984), vol. 58, pp. 25-87.
Mol Pharm. (1977) 13, pp. 362-367.
J. Med. Chem. (1974) vol. 17, No. 1, pp. 1-5.
CA 87:157681s.
CA 97:173875v.
J. Chem. Soc. Dalton Trans (1982) pp. 1433-1438.
J. Chem. Soc., Chem. Comm. (1982) pp. 779-781.
J. Inorg. Biochem. (1982) vol. 16, pp. 21-32.
Inorg. Chem. (1983), pp. 480-485.
J. Polym. Sci.: Pol. Chem. Ed. (1976), vol. 14, pp. 2155-2165.
J. Am. Chem. Soc. (1979), vol. 101, pp. 6534-6541.
J. Med. Chem. (1979), vol. 22, pp. 1281-1283.
J. Med. Chem. (1980), vol. 23, pp. 1130-1133.
Ann. N.Y. Acad. Sci. (1981), pp. 425-435.
Tet. Lett. (1981), vol. 22, pp. 2739-2742.
In. Chem. (1982), vol. 21, pp. 2209-2215.
J. Am. Chem. Soc. (1981), vol. 103, pp. 5133-5140.
In. Chem. (1982), vol. 21, pp. 3437-3442.
Biochem. (1983), vol. 22, pp. 1621-1630.
J. Pharm. Exp. Therap. (1984), vol. 228, pp. 676-681.
Rad. Research (1984), vol. 99, pp. 85-105.
Itoh et al, "The Journal of Antibiotics", vol. XXXII, No. 11, pp. 1089-1095 (Nov. 1979).
Aktieselskabet (U.K. Patent 778,871).
Barker et al, CA 92:179021g.
The Journal of Antibiotics, vol. 32, No. 11, 1979, pp. 1096-1103.
Hider et al (U.K. Patent Application GBA 2117766).
Atkinson et al (U.S. Pat. No. 4,358,455).
McInnes et al, Journal of the Chemical Society, Chemical Communications, 1974, No. 8, 281-282.
Neilands, Science, 1967, 156, 1443-1447.
Dittmar et al, 1974, 17, 753-756.
Bernstein et al (U.S. 2,742,476).
Durbin, P. W. et al, "Kinetics of Plutonium Deposition in the Mours," Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Lab. (Apr. 1985).
Durbin, P. W. et al, "New Sequestering Agents for the Actinides . . . ," Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Lab.
Raymond, K. N., "Specific Sequestering Agents for Iron and Actinides," in Environmental Inorganic Chemistry (VCH Publishers, Inc. 1985).
Riley, P. E. et al, "Specific Sequestering Agents for the Actinides. 9. Synthesis of Metal Complexes of 1-Hydroxy-2-Pyridinone . . . , ".
Inorganic Chemistry 22 (1983), pp. 3940 et seq. This document discusses possible use of the HOPO group in iron(III) and actinide chelation.
Scarrow, R. C. et al, "Ferric Ion Sequestering Agents . . . , " Inorganic Chemistry 24 (1985), pp. 954 et seq.
Scarrow et al, CA 102:124493g.
Raymond et al, CA 103:192911n.
CA 92:130476r.
CA 64:3504d.
CA 93:130476r.
CA 75:115362k.
CA 94:41144j.
Weatherall et al. (eds.), Oxford Textbook Medicine, Ox. Univ. Press, vol. 1 (1983), p. 7.

Affiliated with

Also associated with

Rating

Pharmaceutically active zinc complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically active zinc complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active zinc complexes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1335708